title: Counting costs. Patients will suffer from limits on Alzheimer's drugs.
abstract: Draft guidelines from the National Institute for Health and Clinical Excellence (NICE), currently out for consultation, have suggested that drugs for the treatment of Alzheimer's disease should not be prescribed on the NHS. If this becomes policy, much of the proactive work in dementia care could be lost.
authors.affiliation: Manchester Memory Clinic, Wythenshawe Hospital.
authors.forename: Sean
authors.initials: S
authors.lastname: Page
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics; D002800:Cholinesterase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics; D004739:England; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D018697:Nootropic Agents / Q000191:economics / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D014852:Wales
chemical_list: D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents